IGM Biosciences, Inc. IGMS

Full chart Compare
Set alert

Price alert · IGMS

All alert types
1.27 0.00 (+0.00%)

At closeAug 14, 2025, 4:00 PM EDT

1.27 Day range 1.27
6.15 52-week range 22.50
YTD
-79.21%
1 year
-85.70%

Revenue & Expenses

Other Income → Expenses: $21.90MExpenses → Gross Loss: $6.43MExpenses → Selling, General & Admin: $50.41MExpenses → Research & Development: $160.85MNet Loss → Expenses: $195.79MRevenue → Cost of Revenue: $2.68MOther Income$21.90MNet Loss$195.79MCost of Revenue$9.11MExpenses$217.69MGross Loss$6.43MSelling, General & Admin$50.41MResearch & Development$160.85MRevenue$2.68M

Latest period ending Dec 31, 2024 · select a line to chart its full history

IGMS annual income statement
Fiscal yearFY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021FY 2020 Dec 31, 2020
2.68M2.13M1.07M00
2.68M2.13M1.07M00
-208.58M-263.46M-227.96M-165.32M-83.28M
-195.79M-246.42M-221.10M-165.16M-81.36M
-3.24-4.71-5.32-4.93-2.65
IGMS annual balance sheet
Fiscal yearFY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021FY 2020 Dec 31, 2020
26.66M113.11M121.92M134.03M241.08M
265.71M423.41M513.50M298.13M408.63M
217.54M220.18M226.24M53.22M26.82M
45.19M40.51M41.17M28.76M12.24M
48.17M203.23M287.26M244.91M381.81M
IGMS annual cash flow
Fiscal yearFY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021FY 2020 Dec 31, 2020
-153.00M-192.23M-5.85M-124.98M-67.88M
64.16M68.36M-225.64M15.46M58.29M
2.39M115.07M219.38M2.48M214.78M
-5.81M-12.38M-10.21M-13.24M-17.50M
-86.45M-8.81M-12.12M-107.05M205.19M